Wang Y. et al. demonstrated the anti-fibrotic capabilities of BM-MSC-derived EVs loaded with EPO (EPO-EVs) in an in vivo UUO-CKD murine model and an in vitro model of TGF-β1-induced fibrosis [70]. The gene discussed is EPO; the disease is chronic kidney disease.